arxiv: 2604.16455 · v1 · submitted 2026-04-07 · ⚛️ physics.bio-ph · cond-mat.mtrl-sci· physics.app-ph· physics.chem-ph· physics.med-ph

Recognition: no theorem link

Drug-delivery Ca-Mg silicate scaffolds encapsulated in PLGA

A. Jadidi, E. Salahinejad, E. Sharifi, L. Tayebi

Authors on Pith no claims yet

Pith reviewed 2026-05-10 17:40 UTC · model grok-4.3

classification ⚛️ physics.bio-ph cond-mat.mtrl-sciphysics.app-phphysics.chem-phphysics.med-ph

keywords bredigite scaffoldsPLGA coatingvancomycin deliverybone tissue engineeringdrug release kineticscytocompatibilitybioactive ceramicsantibiotic-loaded implants

0 comments

The pith

PLGA coatings on bredigite scaffolds slow vancomycin release, buffer pH, and raise cell viability while preserving porosity for bone repair.

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The paper develops porous bredigite scaffolds loaded with the antibiotic vancomycin and then coated with PLGA polymer. The goal is to create implants that both support bone tissue growth and deliver antibiotics locally to prevent infection. Without the coating, the scaffolds release the drug too quickly and show poor compatibility with stem cells due to rapid material breakdown. The PLGA layer slows the release, stabilizes the surrounding pH, and significantly improves cell survival rates in lab tests. This approach aims to combine tissue engineering with controlled drug delivery in a single biodegradable structure.

Core claim

Bioresorbable bredigite porous scaffolds were fabricated by a foam replica method, loaded with vancomycin hydrochloride and encapsulated in PLGA coatings. The bare sample exhibited a burst release of vancomycin and low biocompatibility with dental pulp stem cells due to fast bioresorption. While keeping the desirable characteristics of pores for tissue engineering, the biodegradable PLGA coatings modified the drug release kinetics, buffered physiological pH and hence improved the cell viability of the vancomycin-loaded scaffolds considerably.

What carries the argument

The biodegradable PLGA coating on vancomycin-loaded bredigite scaffolds, which slows drug release from burst to controlled, buffers pH, and enhances cytocompatibility without blocking pores.

If this is right

The coated scaffolds provide sustained antibiotic release suitable for preventing infection at bone defect sites.
Dental pulp stem cell viability rises because pH is stabilized and initial drug burst is reduced.
The open porous network stays available for cell infiltration and new tissue growth.
A single scaffold structure now serves both mechanical support and local drug delivery functions.

Where Pith is reading between the lines

These are editorial extensions of the paper, not claims the author makes directly.

This coating method could lower reliance on systemic antibiotics during orthopedic procedures.
Similar polymer encapsulation might be tested on other calcium-magnesium silicate compositions or different antibiotics.
Coating thickness could be varied to match release profiles to specific healing timelines.
Long-term animal studies would be required to check whether the dual function actually accelerates bone repair.

Load-bearing premise

That the observed in vitro improvements in drug release and cell viability from the PLGA coating will carry over to effective in vivo bone regeneration and infection control.

What would settle it

An in vivo test in which coated scaffolds show no reduction in infection rates or bone formation compared with uncoated ones, or in which the coating causes scaffold collapse or blocked pores.

Figures

Figures reproduced from arXiv: 2604.16455 by A. Jadidi, E. Salahinejad, E. Sharifi, L. Tayebi.

**Figure 2.** Figure 2: FESEM micrographs of the bare (a, b), 5% PLGA-coated (c, d) and 10% PLGA [PITH_FULL_IMAGE:figures/full_fig_p013_2.png] view at source ↗

**Figure 3.** Figure 3: Cross-sectional FESEM micrographs of the 5% (a, b) and 10% (c, d) PLGA-coated [PITH_FULL_IMAGE:figures/full_fig_p013_3.png] view at source ↗

**Figure 4.** Figure 4: FTIR spectra of the bare vancomycin-free (a), bare vancomycin-loaded (b) and [PITH_FULL_IMAGE:figures/full_fig_p015_4.png] view at source ↗

**Figure 5.** Figure 5: Concentration (a) and percentage (b) of vancomycin released from the different [PITH_FULL_IMAGE:figures/full_fig_p017_5.png] view at source ↗

**Figure 6.** Figure 6: pH variations of the SBF in contact with the different scaffolds. [PITH_FULL_IMAGE:figures/full_fig_p019_6.png] view at source ↗

**Figure 7.** Figure 7: MTT results of the cell cultures on the different scaffolds, where *, Δ, ֍ and ♠ [PITH_FULL_IMAGE:figures/full_fig_p020_7.png] view at source ↗

**Figure 8.** Figure 8: FESEM micrograph of a cell cultured on the vancomycin-impregnated 10% PLGA [PITH_FULL_IMAGE:figures/full_fig_p021_8.png] view at source ↗

read the original abstract

The aim of this work is to develop dual-functional scaffolds for bone tissue regeneration and local antibiotic delivery applications. In this respect, bioresorbable bredigite (Ca7MgSi4O16) porous scaffolds were fabricated by a foam replica method, loaded with vancomycin hydrochloride and encapsulated in poly lactic-co-glycolic acid (PLGA) coatings. Field emission scanning electron microscopy, Archimedes porosimetry and Fourier-transform infrared spectroscopy were used to characterize the structure of the scaffolds. The drug delivery kinetics and cytocompatibility of the prepared scaffolds were also studied in vitro. The bare sample exhibited a burst release of vancomycin and low biocompatibility with respect to dental pulp stem cells based on the MTT assay due to the fast bioresorption of bredigite. While keeping the desirable characteristics of pores for tissue engineering, the biodegradable PLGA coatings modified the drug release kinetics, buffered physiological pH and hence improved the cell viability of the vancomycin-loaded scaffolds considerably.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit. Tearing a paper down is the easy half of reading it; the pith above is the substance, this is the friction.

Desk Editor's Note private letter to a colleague

The PLGA coating on vancomycin-loaded bredigite scaffolds slows burst release, buffers pH, and raises cell viability in vitro while keeping porosity intact, but this is a standard materials tweak with no new principle.

read the letter

The main point is that these PLGA-encapsulated bredigite scaffolds cut the initial vancomycin dump, stabilize pH, and improve dental pulp stem cell survival in the MTT tests compared to the uncoated versions, all without wrecking the pore network needed for tissue ingrowth. They made the scaffolds by foam replica, loaded the drug, then added the PLGA layer. Standard checks with FESEM, Archimedes porosity, and FTIR confirm the structure and chemistry stay reasonable. Release curves and cell assays back the claim that the coating counters the fast resorption issues of bare bredigite. The logic holds inside the in vitro setup. What they did well is show a practical fix for a known problem with these silicates in a dual-function scaffold. The data line up with the description and the causal steps make sense without hidden assumptions. The soft spots are that everything stays in the dish. No in vivo bone defect or infection model appears, so the jump to real orthopedic or dental use rests on the usual extrapolation. The gains are called considerable but the paper would be stronger with explicit numbers, error bars, and stats in the main text rather than just the abstract. It is also incremental; the methods are routine and the combination does not introduce a fresh mechanism. This paper is for biomaterials groups already working on silicate scaffolds or local antibiotic delivery for bone. Someone building a similar system could pull the recipe and the release/viability numbers as a starting point. I would send it for peer review. The experiments are grounded enough that referees can check the protocols and data quality, even if the work needs more in vivo follow-up or controls.

Referee Report

2 major / 2 minor

Summary. The manuscript reports fabrication of porous bredigite (Ca7MgSi4O16) scaffolds by foam replica method, loaded with vancomycin hydrochloride, and encapsulated in PLGA coatings for dual bone tissue regeneration and local antibiotic delivery. Characterization used FESEM, Archimedes porosimetry, and FTIR. In vitro drug release kinetics and cytocompatibility (MTT assay with dental pulp stem cells) showed bare scaffolds with burst release and low viability due to fast bioresorption, while PLGA coatings modified release, buffered pH, and considerably improved viability while preserving porosity.

Significance. If the in vitro results hold with proper quantification, the work offers a straightforward polymer-coating strategy to mitigate fast resorption issues in Ca-Mg silicate scaffolds, enabling controlled antibiotic release and better cell compatibility for infected bone defect applications. The experimental approach is direct and avoids circularity or unstated models. However, the magnitude of improvement remains unquantified in the provided text, limiting evaluation of practical significance, and in vivo translation is unaddressed.

major comments (2)

[Abstract] Abstract: The central claim that PLGA coatings 'modified the drug release kinetics, buffered physiological pH and hence improved the cell viability of the vancomycin-loaded scaffolds considerably' supplies no quantitative data, error bars, statistical tests, specific release percentages, pH values, or MTT viability numbers. This absence undermines assessment of the effect size and load-bearing support for the improvement claim.
[Results] Results (drug release and cytocompatibility sections): Detailed profiles (cumulative release vs. time, pH buffering curves, MTT absorbance or viability percentages with replicates and controls) are required to substantiate the modifications and improvements; without them the causal link from coating to reduced burst and higher viability cannot be evaluated.

minor comments (2)

[Methods] Methods: Expand on exact parameters for foam replica fabrication, vancomycin loading concentration, PLGA coating thickness or concentration, and incubation conditions for release and MTT assays to support reproducibility.
[Discussion] Discussion: Clarify the mechanistic link between pH buffering by PLGA degradation products and the observed cell viability increase, with reference to relevant literature on bredigite resorption effects.

Simulated Author's Rebuttal

2 responses · 0 unresolved

We thank the referee for the constructive comments on our manuscript. We agree that the abstract and results sections would benefit from more explicit quantitative data to support the claims regarding drug release modification, pH buffering, and improved cytocompatibility. We have revised the manuscript accordingly to address these points directly.

read point-by-point responses

Referee: [Abstract] Abstract: The central claim that PLGA coatings 'modified the drug release kinetics, buffered physiological pH and hence improved the cell viability of the vancomycin-loaded scaffolds considerably' supplies no quantitative data, error bars, statistical tests, specific release percentages, pH values, or MTT viability numbers. This absence undermines assessment of the effect size and load-bearing support for the improvement claim.

Authors: We agree that the abstract would be strengthened by including quantitative metrics. In the revised manuscript, we have updated the abstract to report specific values from our experiments, such as the percentage reduction in initial burst release, stabilized pH ranges, and MTT viability percentages (with error bars and statistical tests) for the PLGA-coated versus bare scaffolds. revision: yes
Referee: [Results] Results (drug release and cytocompatibility sections): Detailed profiles (cumulative release vs. time, pH buffering curves, MTT absorbance or viability percentages with replicates and controls) are required to substantiate the modifications and improvements; without them the causal link from coating to reduced burst and higher viability cannot be evaluated.

Authors: The figures in the original manuscript already display the cumulative release profiles, pH curves, and MTT results. To improve clarity and allow direct evaluation of the causal effects, we have expanded the textual descriptions in the results section to include specific numerical data points, time-dependent values, replicate details, control comparisons, error bars, and statistical analyses supporting the reduced burst release and viability improvements. revision: yes

Circularity Check

0 steps flagged

No significant circularity: purely experimental study

full rationale

This paper reports an experimental materials study on fabricating bredigite scaffolds, loading them with vancomycin, applying PLGA coatings, and measuring outcomes via direct characterization (FESEM, Archimedes porosimetry, FTIR) and in vitro assays (drug release kinetics, pH buffering, MTT cell viability). No mathematical derivations, models, equations, fitted parameters, or first-principles predictions exist. All claims rest on empirical data without any load-bearing steps that reduce to self-definitions, self-citations, or renamings. The central observation—that PLGA coating alters release and improves viability—is a straightforward experimental result, not a constructed equivalence.

Axiom & Free-Parameter Ledger

0 free parameters · 0 axioms · 0 invented entities

This is an experimental materials science study with no mathematical modeling, free parameters, axioms, or invented entities. Claims rest entirely on standard characterization and in vitro assay techniques.

pith-pipeline@v0.9.0 · 5487 in / 1203 out tokens · 49161 ms · 2026-05-10T17:40:37.149039+00:00 · methodology

discussion (0)

Reference graph

Works this paper leans on

1 extracted references · 1 canonical work pages

[3]

Annual Review of Materials Science 28, 271-298

The material bone: structure-mechanical function relations. Annual Review of Materials Science 28, 271-298. This is the accepted manuscript (postprint) of the following article: A. Jadidi, E. Salahinejad, E. Sharifi, L. Tayebi, Drug-delivery Ca-Mg silicate scaffolds encapsulated in PLGA, International Journal of Pharmaceutics, 589 (2020) 119855. https://d...

work page doi:10.1016/j.ijpharm.2020.119855 2020